Evidence map›Paper›PMID 32117320›Full record

ArticleFrontiers in immunology2020

Hepatocyte-Specific Deletion of AMPKα1 Results in Worse Outcomes in Mice Subjected to Sepsis in a Sex-Specific Manner.

Satoshi Kikuchi, Giovanna Piraino, Michael O'Connor, Vivian Wolfe, Kiana Ridings, Patrick Lahni, Basilia Zingarelli

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Targeting AMP-activated protein kinase in sepsis.Frontiers in endocrinology · 2024
    Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Satoshi KikuchiDepartment of Emergency Medicine, Ehime University, Toon, Japan.
Giovanna PirainoDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Michael O'ConnorDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Vivian WolfeDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Kiana RidingsDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Patrick LahniDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Basilia ZingarelliDivision of Critical Care Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States.
Cincinnati Children's Hospital Medical Center · USEhime University · JP

Funding

Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
PPARgamma and PPARgamma agonists in septic shockR01GM067202 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI ZINGARELLI, BASILIA · 2003 to 2015
$3.9M
AGE-DEPENDENT MECHANISMS OF METABOLIC RECOVERY IN HEMORRHAGIC SHOCKR01GM115973 · NIGMS · CINCINNATI CHILDRENS HOSP MED CTR · PI ZINGARELLI, BASILIA · 2015 to 2022
$2.7M
NIDDK NIH HHS P30 DK078392NIGMS NIH HHS R01 GM067202NIGMS NIH HHS R01 GM115973
6 · The paper itself

Abstract

Alterations in the energy homeostasis contribute to sepsis-mediated multiple organ failure. The liver plays a central role in metabolism and participates to the innate immune and inflammatory responses of sepsis. Several clinical and experimental studies have suggested that females are less susceptible to the adverse outcome of sepsis. However, underlying mechanisms of organ damage in sepsis remain largely undefined. AMP-activated protein kinase (AMPK) is an important regulator of mitochondrial quality control. The AMPK catalytic α1 isoform is abundantly expressed in the liver. Here, we determined the role of hepatocyte AMPKα1 in sepsis by using hepatocyte-specific AMPKα1 knockout mice (H-AMPKα1 KO) generated with Cre-recombinase expression under the control of the albumin promoter. Using a clinically relevant model of polymicrobial sepsis by cecal ligation and puncture (CLP), we observed that male H-AMPKα1 KO mice had higher plasma levels of tumor necrosis factor-α and interleukin-6 and exhibited a more severe liver and lung injury than male H-AMPKα1 WT mice, as evaluated by histology and neutrophil infiltration at 18 h after CLP. Plasma levels of interleukin-10 and the keratinocyte-derived chemokine were similarly elevated in both KO and WT male mice. At transmission electron microscopy analysis, male H-AMPKα1 KO mice exhibited higher liver mitochondrial damage, which was associated with a significant decrease in liver ATP levels when compared to WT mice at 18 h after sepsis. Mortality rate was significantly higher in the male H-AMPKα1 KO group (91%) when compared to WT mice (60%) at 7 days after CLP. Female H-AMPKα1 WT mice exhibited a similar degree of histological liver and lung injury, but significantly milder liver mitochondrial damage and higher autophagy when compared to male WT mice after CLP. Interestingly, H-AMPKα1 KO female mice had lower organ neutrophil infiltration, lower liver mitochondrial damage and lower levels of cytokines than WT female mice. There was no significant difference in survival rate between WT and KO mice in the female group. In conclusion, our study demonstrates that AMPKα1 is a crucial hepatoprotective enzyme during sepsis. Furthermore, our results suggest that AMPK-dependent liver metabolic functions may influence the susceptibility to multiple organ injury in a sex-dependent manner.

Indexed as

AMP-Activated Protein KinasesAnimalsAutophagyDisease Models, AnimalFemaleGene Knockout TechniquesHepatocytesInterleukin-6LiverLung InjuryMaleMiceMice, Inbred C57BLMice, KnockoutMitochondriaNeutrophil InfiltrationAMP-Activated Protein KinasesInterleukin-6interleukin-6, mousePrkaa1 protein, mouseTumor Necrosis Factor-alphaAMPKα1cecal ligation and punctureCre-loxfemale sexliver injurylung injurymitochondria

Identifiers

PMID32117320
PMCPMC7031478
OpenAlexW3005952460

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.